Krainer Adrian R. 4
4 · Stoke Therapeutics, Inc. · Filed Nov 18, 2025
Insider Transaction Report
Form 4
Krainer Adrian R.
Director
Transactions
- Sale
Common Stock
2025-11-14$26.61/sh−19,790$526,693→ 384,928 total - Sale
Common Stock
2025-11-14$27.34/sh−20,682$565,365→ 364,246 total
Footnotes (3)
- [F1]The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.975 to $26.97 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.98 to $27.88 per share, inclusive.